Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Castle Biosciences, Inc. (CSTL)
USD23.84
+0.72 (+3.13%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
505 South Friendswood Drive 77546
Friendswood, TX, US
Friendswood, TX, US
CEO
Derek J. Maetzold
Website
castlebiosciences.com
IPO
2019-07-25
CIK 1447362 ISIN US14843C1053
Description
Castle Biosciences, Inc. functions as a commercial-stage diagnostics firm, with its primary objective being the provision of both diagnostic and prognostic testing services, specifically targeting various dermatological cancers. Their flagship product, DecisionDx-Melanoma, represents an advanced multi-gene expression profile (GEP) assay engineered to assess the probability of metastasis in patients afflicted with invasive cutaneous melanoma. In addition to their leading solution, the company has created several other specialized, proprietary tests. Among these is DecisionDx-UM, a GEP test tailored to forecast the risk of metastasis for individuals with uveal melanoma, a less common malignancy of the eye. Another key offering is DecisionDx-SCC, a distinctive 40-gene expression profile test that utilizes a patient's unique tumor biology to predict their specific risk of squamous cell carcinoma metastasis, particularly for those presenting with recognized risk factors. Moreover, they offer DecisionDx DiffDx-Melanoma and myPath Melanoma, both proprietary GEP tests employed to assist in the accurate diagnosis of ambiguous pigmented lesions. These specialized testing services are provided by Castle Biosciences to patients predominantly through their healthcare providers. The organization commenced operations in 2007 and maintains its corporate headquarters in Friendswood, Texas.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD23.84
+0.72 (+3.13%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
399.6K
Beta
1.02
Float Shares
25.26M
Free Float %
83.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.98% | -15.98% | -17.68% | -40.31% | -45.32% | -51.05% | +11.74% | -16.75% | -63.46% | -11.03% | -11.03% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
23.84
Low
40.00
+67.8%
Consensus
47.80
+100.5%
Median
50.00
+109.7%
High
52.00
+118.1%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 8 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
40.00
+67.8%
|
| Last Quarter | 1 |
40.00
+67.8%
|
| Last Year | 7 |
47.43
+98.9%
|
| All Time | 16 |
42.31
+77.5%
|
Quality scores
Altman Z-Score
4.67
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+3.7% Q1'26: -4.9% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%-233.9% Q1'26: +45.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-1.7% Q1'26: -41.3% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-8.6% Q1'26: -22.0% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%-14.1% Q1'26: -31.1% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%-0.9% ★ Q1'26: +4.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×3.25× ★ Q1'26: -0.64× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 5 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
51.87M
est: 45.96M (+12.9%)
|
62.65M
est: 61.11M (+2.5%)
|
94.09M
est: 92.78M (+1.4%)
|
137.04M
est: 135.89M (+0.8%)
|
219.79M
est: 287.59M (-23.6%)
|
332.07M
est: 327.49M (+1.4%)
|
344.23M
est: 336.22M (+2.4%)
|
351.77M
348.87M – 356.13M
+4.6% YoY
|
392.53M
389.28M – 397.39M
+11.6% YoY
|
434.55M
430.95M – 439.93M
+10.7% YoY
|
469.70M
465.82M – 475.52M
+8.1% YoY
|
507.90M
503.70M – 514.19M
+8.1% YoY
|
| EBITDA |
10.28M
est: -9.36M (+209.8%)
|
-7.09M
est: -12.44M (+43.0%)
|
-36.60M
est: -38.79M (+5.6%)
|
-58.34M
est: -45.47M (-28.3%)
|
-45.02M
est: -50.15M (+10.2%)
|
38.14M
est: -57.11M (+166.8%)
|
11.34M
est: -58.63M (+119.3%)
|
-61.34M
-62.10M – -60.83M
-4.6% YoY
|
-68.44M
-69.29M – -67.88M
-11.6% YoY
|
-75.77M
-76.71M – -75.15M
-10.7% YoY
|
-81.90M
-82.92M – -81.22M
-8.1% YoY
|
-88.56M
-89.66M – -87.83M
-8.1% YoY
|
| EBIT |
9.92M
est: -11.43M (+186.8%)
|
-7.57M
est: -15.19M (+50.2%)
|
-40.01M
est: -42.48M (+5.8%)
|
-68.89M
est: -86.82M (+20.7%)
|
-57.35M
est: -69.46M (+17.4%)
|
22.14M
est: -79.10M (+128.0%)
|
-29.43M
est: -81.21M (+63.8%)
|
-84.97M
-86.02M – -84.27M
-4.6% YoY
|
-94.81M
-95.99M – -94.03M
-11.6% YoY
|
-104.96M
-106.26M – -104.09M
-10.7% YoY
|
-113.45M
-114.86M – -112.51M
-8.1% YoY
|
-122.68M
-124.20M – -121.67M
-8.1% YoY
|
| Net Income |
5.28M
est: -28.60M (+118.5%)
|
-10.28M
est: -11.87M (+13.3%)
|
-31.29M
est: -30.90M (-1.3%)
|
-67.14M
est: -45.27M (-48.3%)
|
-57.47M
est: -3.31M (-1,638.7%)
|
18.25M
est: 11.23M (+62.4%)
|
-24.16M
est: -29.59M (+18.4%)
|
-38.98M
-39.50M – -38.46M
-31.7% YoY
|
-23.47M
-23.78M – -23.15M
+39.8% YoY
|
-11.16M
-35.07M – 2.61M
+52.4% YoY
|
9.28M
9.18M – 9.42M
+183.1% YoY
|
21.45M
21.22M – 21.79M
+131.3% YoY
|
| SGA |
29.84M
est: 38.20M (-21.9%)
|
48.13M
est: 50.79M (-5.2%)
|
86.74M
est: 92.01M (-5.7%)
|
143.00M
est: 112.95M (+26.6%)
|
180.15M
est: 233.16M (-22.7%)
|
200.05M
est: 265.51M (-24.7%)
|
229.32M
est: 272.59M (-15.9%)
|
285.20M
282.84M – 288.73M
+4.6% YoY
|
318.24M
315.61M – 322.18M
+11.6% YoY
|
352.31M
349.39M – 356.67M
+10.7% YoY
|
380.81M
377.66M – 385.52M
+8.1% YoY
|
411.78M
408.37M – 416.88M
+8.1% YoY
|
| EPS |
0.35
est: -0.98 (+135.8%)
|
-0.54
est: -0.41 (-33.1%)
|
-1.24
est: -1.46 (+15.0%)
|
-2.58
est: -2.72 (+5.2%)
|
-2.14
est: -0.11 (-1,781.8%)
|
0.66
est: 0.39 (+68.4%)
|
-0.83
est: -1.04 (+20.1%)
|
-1.34
-1.36 – -1.33
-29.1% YoY
|
-0.81
-0.82 – -0.80
+39.8% YoY
|
-0.50
-1.21 – 0.09
+38.1% YoY
|
0.32
0.32 – 0.33
+164.0% YoY
|
0.74
0.73 – 0.75
+131.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-20 | Canaccord Genuity | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
2.99M
OE per share TTM
0.12
Owner's Yield
0.40%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
21.4%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
35
Total invested
56.20M
Insider transactions (90d)
1
Beneficial owners (>5%)
22
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Wasatch Advisors, Inc. 87-0319391 | 3.12M | 12.30% | 3.12M | — | 3.12M | — | IA | — | 2022-02-10 | ↗ |
| 2 | ARK Investment Management LLC | 2.55M | 10.44% | 2.55M | — | 2.55M | — | IA | — | 2021-02-10 | ↗ |
| 3 | S | 2.17M | 8.05% | 1.85M | — | 2.17M | — | IA | of Massachusetts | 2024-02-14 | ↗ |
| 4 | (1) BlackRock, Inc. | 1.80M | 7.10% | 1.78M | — | 1.80M | — | HC | Delaware | 2022-02-04 | ↗ |
| 5 | Derek J. Maetzold | 1.66M | 6.62% | 1.66M | — | 1.66M | — | IN | United States of America | 2021-02-17 | ↗ |
| 6 | The Vanguard Group - 23-1945930 | 1.39M | 5.29% | — | 17.5K | 1.36M | — | IA | Pennsylvania | 2023-02-09 | ↗ |
| 7 | Johan D. Swildens | 1.25M | 7.30% | — | 1.25M | — | 1.25M | IN | Delaware | 2020-02-05 | ↗ |
| 8 | Dr. Garheng Kong (“Kong”) | 1.18M | 6.00% | 1.18M | — | 1.18M | 10.00 | IN | U.S. Citizen | 2020-07-14 | ↗ |
| 9 | HealthQuest Venture Management, L.L.C. (“HealthQuest Management”) | 1.18M | 6.00% | 1.18M | — | 1.18M | 10.00 | OO | Delaware | 2020-07-14 | ↗ |
| 10 | Sofinnova HealthQuest Partners, L.P. (“HealthQuest”) | 1.18M | 6.00% | 1.18M | — | 1.18M | 10.00 | PN | Delaware | 2020-07-14 | ↗ |
| 11 | Page 2 of 4 Pages | 1.02M | 4.00% | 871.5K | 150.6K | 871.5K | 150.6K | IN | — | 2022-02-11 | ↗ |
| 12 | BioBrit, LLC | 743.4K | 3.00% | — | 743.4K | — | 743.4K | OO | United States of America | 2021-02-17 | ↗ |
| 13 | Daniel Bradbury | 743.4K | 3.00% | — | 743.4K | — | 743.4K | IN | United States of America | 2021-02-17 | ↗ |
| 14 | III | 741.3K | 3.10% | 112.2K | 629.1K | 112.2K | 629.1K | IN | Delaware | 2021-02-16 | ↗ |
| 15 | 2013 GP, LLC | 503.4K | 2.10% | 1.5K | 501.9K | 1.5K | 501.9K | OO | Delaware | 2021-02-16 | ↗ |
| 16 | 2013, L.P. | 501.9K | 2.10% | — | 501.9K | — | 501.9K | PN | Delaware | 2021-02-16 | ↗ |
| 17 | 2018 GP, LLC | 125.0K | 0.50% | — | 125.0K | — | 125.0K | OO | Delaware | 2021-02-16 | ↗ |
| 18 | QP 2018, L.P. | 67.4K | 0.30% | — | 67.4K | — | 67.4K | PN | Delaware | 2021-02-16 | ↗ |
| 19 | 2018, L.P. | 57.6K | 0.20% | — | 57.6K | — | 57.6K | PN | Delaware | 2021-02-16 | ↗ |
| 20 | Industry Ventures Healthcare, LLC | 10.00 | 0.00% | — | — | — | — | OO | — | 2021-02-12 | ↗ |
| 21 | Industry Ventures Management VII, LLC | — | 0.00% | — | — | — | — | OO | — | 2021-02-12 | ↗ |
| 22 | United States of America | — | 0.00% | — | — | — | — | IN | — | 2021-02-12 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
35
-162 vs prev Q
New positions
2
Closed positions
162
Increased
12
Reduced
14
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 3.11M -84.7K (-2.7%) | 120.79M +48.2M (+66.3%) | 12.40% +1.364 pp | 0.00% +0.001 pp | USD27.86 +39.6% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 2.20M +27.5K (+1.3%) | 85.57M +36.1M (+73.0%) | 8.78% +1.269 pp | 0.00% +0.001 pp | USD37.77 +3.0% | 26 qtrs — |
| 3 | RTW INVESTMENTS, LP | 2.12M +2.1M (+100.0%) | 82.28M +82.3M (+100.0%) | 8.44% +8.444 pp | 0.82% +0.824 pp | USD38.90 +0.0% | 1 qtrs NEW |
| 4 | PRINCIPAL FINANCIAL GROUP INC | 1.81M +13.3K (+0.7%) | 70.32M +29.5M (+72.1%) | 7.22% +1.010 pp | 0.04% +0.015 pp | USD25.78 +50.9% | 23 qtrs — |
| 5 | PORTOLAN CAPITAL MANAGEMENT, LLC | 1.73M +214.4K (+14.1%) | 67.28M +32.8M (+95.0%) | 6.90% +1.664 pp | 3.60% +1.738 pp | USD23.14 +68.1% | 15 qtrs — |
| 6 | DIMENSIONAL FUND ADVISORS LP | 1.14M -330.3K (-22.4%) | 44.49M +10.9M (+32.6%) | 4.57% -0.532 pp | 0.01% +0.002 pp | USD24.85 +56.5% | 21 qtrs — |
| 7 | SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1.06M +658.7K (+164.7%) | 41.18M +32.1M (+352.2%) | 4.23% +2.843 pp | 0.86% +0.667 pp | USD32.81 +18.6% | 2 qtrs — |
| 8 | STATE STREET CORP | 736.5K +12.4K (+1.7%) | 28.65M +12.2M (+73.8%) | 2.94% +0.436 pp | 0.00% +0.000 pp | USD40.71 -4.4% | 26 qtrs — |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 714.9K +16.3K (+2.3%) | 27.81M +11.9M (+74.8%) | 2.85% +0.438 pp | 0.00% +0.001 pp | USD38.39 +1.3% | 26 qtrs — |
| 10 | AIGH CAPITAL MANAGEMENT LLC | 624.7K -82.6K (-11.7%) | 24.30M +8.2M (+50.9%) | 2.49% +0.048 pp | 5.88% +1.344 pp | USD22.77 +70.8% | 2 qtrs — |
| 11 | ALLIANZ ASSET MANAGEMENT GMBH | 622.3K -26.1K (-4.0%) | 24.21M +9.4M (+64.0%) | 2.48% +0.242 pp | 0.02% +0.008 pp | USD23.24 +67.4% | 6 qtrs — |
| 12 | PALISADE CAPITAL MANAGEMENT, LP | 567.8K -70.9K (-11.1%) | 22.09M +7.5M (+51.9%) | 2.27% +0.058 pp | 0.65% +0.260 pp | USD31.93 +21.8% | 17 qtrs — |
| 13 | WASATCH ADVISORS LP | 537.2K -131.9K (-19.7%) | 20.90M +5.7M (+37.2%) | 2.14% -0.170 pp | 0.12% +0.042 pp | USD43.95 -11.5% | 26 qtrs — |
| 14 | NUVEEN, LLC | 524.7K -432.4K (-45.2%) | 20.41M -1.4M (-6.3%) | 2.09% -1.216 pp | 0.01% 0.000 pp | USD20.17 +92.9% | 4 qtrs — |
| 15 | SCHRODER INVESTMENT MANAGEMENT GROUP | 492.2K -2.8K (-0.6%) | 19.35M +8.3M (+74.8%) | 1.96% +0.253 pp | 0.01% +0.006 pp | USD20.05 +94.0% | 4 qtrs — |
| 16 | RENAISSANCE TECHNOLOGIES LLC | 493.1K -69.5K (-12.4%) | 19.18M +6.4M (+49.7%) | 1.97% +0.023 pp | 0.03% +0.013 pp | USD24.25 +60.4% | 17 qtrs — |
| 17 | ACADIAN ASSET MANAGEMENT LLC | 390.4K -61.2K (-13.6%) | 15.18M +4.9M (+47.7%) | 1.56% -0.004 pp | 0.02% +0.007 pp | USD22.34 +74.1% | 9 qtrs — |
| 18 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 388.5K +52.6K (+15.7%) | 15.11M +7.5M (+97.6%) | 1.55% +0.389 pp | 0.04% +0.016 pp | USD25.57 +52.1% | 15 qtrs — |
| 19 | CITADEL ADVISORS LLC | 366.4K +115.4K (+46.0%) | 14.25M +8.5M (+149.4%) | 1.46% +0.595 pp | 0.00% +0.001 pp | USD26.53 +46.6% | 26 qtrs — |
| 20 | MILLENNIUM MANAGEMENT LLC | 308.9K -266.2K (-46.3%) | 12.02M -1.1M (-8.2%) | 1.23% -0.756 pp | 0.01% -0.001 pp | USD23.98 +62.2% | 26 qtrs — |
| 21 | EVENTIDE ASSET MANAGEMENT, LLC | 305.0K +305.0K (+100.0%) | 11.86M +11.9M (+100.0%) | 1.22% +1.218 pp | 0.19% +0.185 pp | USD38.90 +0.0% | 1 qtrs NEW |
| 22 | GOLDMAN SACHS GROUP INC | 287.2K -57.9K (-16.8%) | 11.17M +3.3M (+42.2%) | 1.15% -0.047 pp | 0.00% +0.000 pp | USD22.85 +70.2% | 26 qtrs — |
| 23 | KORNITZER CAPITAL MANAGEMENT INC /KS | 267.7K -10.6K (-3.8%) | 10.41M +4.1M (+64.3%) | 1.07% +0.106 pp | 0.22% +0.089 pp | USD40.99 -5.1% | 23 qtrs — |
| 24 | BANK OF AMERICA CORP /DE/ | 263.0K -52.4K (-16.6%) | 10.23M +3.1M (+42.5%) | 1.05% -0.041 pp | 0.00% +0.000 pp | USD26.70 +45.7% | 26 qtrs — |
| 25 | NORTHERN TRUST CORP | 262.2K -20.0K (-7.1%) | 10.20M +3.8M (+58.7%) | 1.05% +0.071 pp | 0.00% +0.001 pp | USD36.91 +5.4% | 26 qtrs — |
| 26 | ADVISORS CAPITAL MANAGEMENT, LLC | 250.7K -3.5K (-1.4%) | 9.75M +4.0M (+68.5%) | 1.00% +0.122 pp | 0.11% +0.043 pp | USD23.20 +67.7% | 19 qtrs — |
| 27 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246.9K +69.7K (+39.4%) | 9.61M +5.6M (+138.1%) | 0.99% +0.373 pp | 0.20% +0.115 pp | USD26.94 +44.4% | 3 qtrs — |
| 28 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 242.5K +4.4K (+1.8%) | 9.43M +4.0M (+74.0%) | 0.97% +0.145 pp | 0.00% +0.001 pp | USD42.46 -8.4% | 25 qtrs — |
| 29 | QUBE RESEARCH & TECHNOLOGIES LTD | 235.5K +14.6K (+6.6%) | 9.16M +4.1M (+82.1%) | 0.94% +0.176 pp | 0.01% +0.004 pp | USD26.06 +49.3% | 6 qtrs — |
| 30 | NEW YORK STATE COMMON RETIREMENT FUND | 233.0K +3.0K (+1.3%) | 9.07M +3.8M (+73.1%) | 0.93% +0.135 pp | 0.01% +0.005 pp | USD32.01 +21.5% | 25 qtrs — |
| 31 | WELLINGTON MANAGEMENT GROUP LLP | 218.6K +218.6K (+100.0%) | 8.50M +8.5M (+100.0%) | 0.87% +0.873 pp | 0.00% +0.002 pp | USD38.90 +0.0% | 5 qtrs — |
| 32 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 205.0K -162.9K (-44.3%) | 7.97M -402.2K (-4.8%) | 0.82% -0.454 pp | 0.05% -0.001 pp | USD25.36 +53.4% | 6 qtrs — |
| 33 | MORGAN STANLEY | 203.6K -66.1K (-24.5%) | 7.92M +1.8M (+29.0%) | 0.81% -0.120 pp | 0.00% +0.000 pp | USD23.78 +63.6% | 26 qtrs — |
| 34 | BRAIDWELL LP | 177.2K -645.6K (-78.5%) | 6.89M -11.8M (-63.2%) | 0.71% -2.138 pp | 0.22% -0.335 pp | USD20.24 +92.2% | 7 qtrs — |
| 35 | JANE STREET GROUP, LLC | 168.6K +145.8K (+637.0%) | 6.56M +6.0M (+1,159.0%) | 0.67% +0.594 pp | 0.00% +0.001 pp | USD36.71 +6.0% | 11 qtrs — |
| 36 | TUDOR INVESTMENT CORP ET AL | 167.2K +81.7K (+95.7%) | 6.50M +4.6M (+234.3%) | 0.67% +0.372 pp | 0.01% +0.009 pp | USD30.26 +28.6% | 8 qtrs — |
| 37 | D. E. SHAW & CO., INC. | 159.7K +67.1K (+72.4%) | 6.21M +4.1M (+194.6%) | 0.64% +0.317 pp | 0.00% +0.002 pp | USD29.79 +30.6% | 5 qtrs — |
| 38 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 159.2K +2.7K (+1.7%) | 6.13M +2.6M (+72.1%) | 0.64% +0.094 pp | 0.01% +0.004 pp | USD20.46 +90.1% | 17 qtrs — |
| 39 | PARKMAN HEALTHCARE PARTNERS LLC | 150.6K -325.0K (-68.3%) | 5.86M -5.0M (-45.9%) | 0.60% -1.044 pp | 0.56% -0.572 pp | USD19.68 +97.7% | 11 qtrs — |
| 40 | BNP PARIBAS ARBITRAGE, SNC | 150.0K +10.1K (+7.2%) | 5.84M +2.6M (+83.2%) | 0.60% +0.115 pp | 0.00% +0.001 pp | USD24.18 +60.9% | 5 qtrs — |
| 41 | UBS GROUP AG | 141.9K -149.5K (-51.3%) | 5.52M -1.1M (-16.8%) | 0.57% -0.441 pp | 0.00% 0.000 pp | USD21.22 +83.3% | 26 qtrs — |
| 42 | INVESCO LTD. | 135.5K +79.6K (+142.6%) | 5.27M +4.0M (+314.4%) | 0.54% +0.348 pp | 0.00% +0.001 pp | USD36.11 +7.7% | 23 qtrs — |
| 43 | EMPOWERED FUNDS, LLC | 121.9K +23.7K (+24.2%) | 4.74M +2.5M (+112.1%) | 0.49% +0.147 pp | 0.04% +0.015 pp | USD25.13 +54.8% | 3 qtrs — |
| 44 | POINT72 ASSET MANAGEMENT, L.P. | 119.5K -217.5K (-64.5%) | 4.65M -3.0M (-39.4%) | 0.48% -0.689 pp | 0.01% -0.008 pp | USD22.77 +70.8% | 7 qtrs — |
| 45 | JPMORGAN CHASE & CO | 90.0K +62.3K (+224.1%) | 3.50M +2.9M (+453.7%) | 0.36% +0.263 pp | 0.00% +0.000 pp | USD35.72 +8.9% | 26 qtrs — |
| 46 | BANK OF NEW YORK MELLON CORP | 87.0K -7.0K (-7.5%) | 3.38M +1.2M (+58.1%) | 0.35% +0.022 pp | 0.00% +0.000 pp | USD33.83 +15.0% | 25 qtrs — |
| 47 | TWO SIGMA INVESTMENTS, LP | 84.1K +58.4K (+227.1%) | 3.27M +2.7M (+458.8%) | 0.34% +0.247 pp | 0.00% +0.004 pp | USD33.13 +17.4% | 23 qtrs — |
| 48 | FRANKLIN RESOURCES INC | 80.6K -19.2K (-19.2%) | 3.14M +863.3K (+38.0%) | 0.32% -0.023 pp | 0.00% +0.000 pp | USD23.88 +62.9% | 8 qtrs — |
| 49 | BIRCHVIEW CAPITAL, LP | 80.6K -30.0K (-27.1%) | 3.14M +617.0K (+24.5%) | 0.32% -0.061 pp | 1.84% -0.066 pp | USD23.58 +65.0% | 9 qtrs — |
| 50 | AMERICAN CENTURY COMPANIES INC | 77.8K -4.7K (-5.7%) | 3.03M +1.1M (+61.0%) | 0.31% +0.025 pp | 0.00% +0.001 pp | USD22.12 +75.9% | 11 qtrs — |
| 51 | BRINKER CAPITAL INVESTMENTS, LLC | 74.7K -1.7K (-2.2%) | 2.90M +1.2M (+67.1%) | 0.30% +0.034 pp | 0.02% +0.008 pp | USD29.12 +33.6% | 19 qtrs — |
| 52 | EAM INVESTORS, LLC | 74.1K +74.1K (+100.0%) | 2.88M +2.9M (+100.0%) | 0.30% +0.296 pp | 0.32% +0.321 pp | USD38.90 +0.0% | 1 qtrs NEW |
| 53 | BARCLAYS PLC | 72.1K +19.8K (+37.9%) | 2.81M +1.3M (+88.2%) | 0.29% +0.107 pp | 0.00% +0.000 pp | USD27.37 +42.1% | 16 qtrs — |
| 54 | UBS ASSET MANAGEMENT AMERICAS INC | 69.6K +12.2K (+21.2%) | 2.71M +1.4M (+107.0%) | 0.28% +0.079 pp | 0.00% +0.000 pp | USD28.09 +38.5% | 24 qtrs — |
| 55 | TREXQUANT INVESTMENT LP | 64.6K -113.8K (-63.8%) | 2.51M -1.5M (-38.1%) | 0.26% -0.359 pp | 0.02% -0.019 pp | USD24.26 +60.3% | 10 qtrs — |
| 56 | AQR CAPITAL MANAGEMENT LLC | 63.9K +13.0K (+25.6%) | 2.48M +1.3M (+114.7%) | 0.26% +0.079 pp | 0.00% +0.001 pp | USD24.73 +57.3% | 5 qtrs — |
| 57 | ENVESTNET ASSET MANAGEMENT INC | 62.0K -5.0K (-7.4%) | 2.41M +886.5K (+58.2%) | 0.25% +0.016 pp | 0.00% +0.000 pp | USD33.74 +15.3% | 20 qtrs — |
| 58 | SWISS NATIONAL BANK | 57.3K +1.3K (+2.3%) | 2.23M +953.9K (+74.8%) | 0.23% +0.035 pp | 0.00% +0.001 pp | USD40.56 -4.1% | 23 qtrs — |
| 59 | SQUAREPOINT OPS LLC | 55.1K +55.1K (+100.0%) | 2.14M +2.1M (+100.0%) | 0.22% +0.220 pp | 0.00% +0.002 pp | USD38.90 +0.0% | 6 qtrs — |
| 60 | HRT FINANCIAL LP | 47.7K +415.0 (+0.9%) | 1.85M +778.0K (+72.4%) | 0.19% +0.027 pp | 0.01% +0.002 pp | USD23.29 +67.0% | 8 qtrs — |
| 61 | PANAGORA ASSET MANAGEMENT INC | 46.0K +24.6K (+115.0%) | 1.79M +1.3M (+267.2%) | 0.18% +0.110 pp | 0.01% +0.004 pp | USD31.40 +23.9% | 2 qtrs — |
| 62 | FMR LLC | 42.3K +13.7K (+48.2%) | 1.64M +995.0K (+153.1%) | 0.17% +0.070 pp | 0.00% +0.000 pp | USD26.85 +44.9% | 16 qtrs — |
| 63 | SEI INVESTMENTS CO | 39.7K +13.0K (+48.4%) | 1.55M +935.8K (+153.5%) | 0.16% +0.066 pp | 0.00% +0.001 pp | USD29.37 +32.4% | 6 qtrs — |
| 64 | RHUMBLINE ADVISERS | 38.5K -5.3K (-12.1%) | 1.50M +500.0K (+50.2%) | 0.15% +0.002 pp | 0.00% +0.000 pp | USD33.16 +17.3% | 24 qtrs — |
| 65 | MACKENZIE FINANCIAL CORP | 37.3K +13.1K (+54.2%) | 1.46M +912.9K (+165.6%) | 0.15% +0.065 pp | 0.00% +0.001 pp | USD29.95 +29.9% | 5 qtrs — |
| 66 | ADVISOR GROUP HOLDINGS, INC. | 36.4K +36.0K (+8,822.5%) | 1.42M +1.4M (+15,192.7%) | 0.15% +0.144 pp | 0.00% +0.002 pp | USD38.71 +0.5% | 22 qtrs — |
| 67 | AMERIPRISE FINANCIAL INC | 35.4K -220.9K (-86.2%) | 1.38M -4.5M (-76.4%) | 0.14% -0.745 pp | 0.00% -0.001 pp | USD22.52 +72.7% | 24 qtrs — |
| 68 | WELLS FARGO & COMPANY/MN | 34.2K +10.2K (+42.7%) | 1.33M +784.8K (+143.7%) | 0.14% +0.054 pp | 0.00% +0.000 pp | USD26.98 +44.2% | 26 qtrs — |
| 69 | PRICE T ROWE ASSOCIATES INC /MD/ | 34.1K +1.5K (+4.7%) | 1.33M +585.0K (+78.7%) | 0.14% +0.024 pp | 0.00% +0.000 pp | USD35.25 +10.4% | 21 qtrs — |
| 70 | CITIGROUP INC | 32.4K +28.2K (+662.9%) | 1.26M +1.2M (+1,203.3%) | 0.13% +0.115 pp | 0.00% +0.001 pp | USD36.70 +6.0% | 26 qtrs — |
| 71 | TWO SIGMA ADVISERS, LP | 29.9K +20.0K (+202.0%) | 1.16M +937.6K (+416.0%) | 0.12% +0.085 pp | 0.00% +0.002 pp | USD33.01 +17.8% | 5 qtrs — |
| 72 | LEGAL & GENERAL GROUP PLC | 29.7K -5.2K (-14.8%) | 1.16M +361.8K (+45.5%) | 0.12% -0.002 pp | 0.00% +0.000 pp | USD28.81 +35.0% | 26 qtrs — |
| 73 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 29.4K -526.0 (-1.8%) | 1.14M +461.6K (+67.8%) | 0.12% +0.014 pp | 0.00% +0.001 pp | USD20.33 +91.3% | 4 qtrs — |
| 74 | PERKINS CAPITAL MANAGEMENT INC | 28.0K -100.0 (-0.4%) | 1.09M +450.1K (+70.2%) | 0.11% +0.015 pp | 0.87% +0.301 pp | USD46.65 -16.6% | 22 qtrs — |
| 75 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 27.7K +3.1K (+12.6%) | 1.08M +517.9K (+92.4%) | 0.11% +0.026 pp | 0.00% +0.001 pp | USD41.38 -6.0% | 26 qtrs — |
| 76 | ALLIANCEBERNSTEIN L.P. | 25.3K -8.1K (-24.3%) | 983.0K +223.2K (+29.4%) | 0.10% -0.015 pp | 0.00% +0.000 pp | USD28.06 +38.6% | 23 qtrs — |
| 77 | TRUIST FINANCIAL CORP | 23.6K +257.0 (+1.1%) | 919.1K +387.0K (+72.7%) | 0.09% +0.014 pp | 0.00% +0.001 pp | USD19.80 +96.5% | 11 qtrs — |
| 78 | ENGINEERS GATE MANAGER LP | 22.9K -23.6K (-50.7%) | 892.7K -166.2K (-15.7%) | 0.09% -0.069 pp | 0.01% -0.002 pp | USD21.42 +81.6% | 9 qtrs — |
| 79 | CAXTON ASSOCIATES LLP | 22.5K +22.5K (+100.0%) | 873.9K +873.9K (+100.0%) | 0.09% +0.090 pp | 0.02% +0.017 pp | USD38.90 +0.0% | 1 qtrs NEW |
| 80 | DEUTSCHE BANK AG\ | 22.4K +5.7K (+34.5%) | 870.7K +491.8K (+129.8%) | 0.09% +0.032 pp | 0.00% +0.000 pp | USD27.11 +43.5% | 26 qtrs — |
| 81 | XTX TOPCO LTD | 22.1K +22.1K (+100.0%) | 860.7K +860.7K (+100.0%) | 0.09% +0.088 pp | 0.02% +0.023 pp | USD38.90 +0.0% | 4 qtrs — |
| 82 | FOX RUN MANAGEMENT, L.L.C. | 21.9K +8.1K (+58.4%) | 851.3K +536.6K (+170.5%) | 0.09% +0.040 pp | 0.13% +0.082 pp | USD28.71 +35.5% | 2 qtrs — |
| 83 | SCHONFELD STRATEGIC ADVISORS LLC | 21.5K -66.2K (-75.5%) | 835.4K -1.2M (-58.2%) | 0.09% -0.218 pp | 0.00% -0.008 pp | USD20.80 +87.0% | 23 qtrs — |
| 84 | SG AMERICAS SECURITIES, LLC | 21.3K +8.2K (+62.8%) | 827.0K +530.0K (+178.5%) | 0.08% +0.040 pp | 0.00% +0.000 pp | USD28.99 +34.2% | 2 qtrs — |
| 85 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20.2K +20.2K (+100.0%) | 785.8K +785.8K (+100.0%) | 0.08% +0.081 pp | 0.00% +0.000 pp | USD38.90 +0.0% | 1 qtrs NEW |
| 86 | HSBC HOLDINGS PLC | 19.5K -13.7K (-41.4%) | 760.3K +11.4K (+1.5%) | 0.08% -0.037 pp | 0.00% +0.000 pp | USD21.48 +81.1% | 8 qtrs — |
| 87 | ALGERT GLOBAL LLC | 19.0K -38.9K (-67.2%) | 738.0K -580.0K (-44.0%) | 0.08% -0.125 pp | 0.01% -0.011 pp | USD22.19 +75.3% | 14 qtrs — |
| 88 | SUMMITTX CAPITAL, L.P. | 17.4K -27.6K (-61.3%) | 677.2K -347.4K (-33.9%) | 0.07% -0.086 pp | 0.02% -0.022 pp | USD22.77 +70.8% | 2 qtrs — |
| 89 | QUEST PARTNERS LLC | 17.1K +2.6K (+17.7%) | 665.8K +334.6K (+101.1%) | 0.07% +0.018 pp | 0.04% +0.016 pp | USD25.56 +52.2% | 8 qtrs — |
| 90 | VERITION FUND MANAGEMENT LLC | 16.8K +1.2K (+7.5%) | 653.9K +297.8K (+83.6%) | 0.07% +0.013 pp | 0.00% +0.001 pp | USD23.11 +68.3% | 5 qtrs — |
| 91 | FIRST BANK & TRUST | 16.7K -3.1K (-15.6%) | 649.9K +199.0K (+44.2%) | 0.07% -0.002 pp | 0.11% +0.030 pp | USD23.79 +63.5% | 6 qtrs — |
| 92 | CREATIVE PLANNING | 16.1K -135.0 (-0.8%) | 627.9K +257.3K (+69.4%) | 0.06% +0.008 pp | 0.00% +0.000 pp | USD25.87 +50.4% | 6 qtrs — |
| 93 | METLIFE INVESTMENT MANAGEMENT, LLC | 15.9K +— (+0.0%) | 617.8K +256.2K (+70.8%) | 0.06% +0.009 pp | 0.00% +0.001 pp | USD40.83 -4.7% | 24 qtrs — |
| 94 | JANUS HENDERSON GROUP PLC | 15.0K +5.9K (+64.6%) | 585.0K +376.8K (+180.9%) | 0.06% +0.028 pp | 0.00% +0.000 pp | USD29.10 +33.7% | 2 qtrs — |
| 95 | LOS ANGELES CAPITAL MANAGEMENT LLC | 23.6K -490.0 (-2.0%) | 572.1K +22.9K (+4.2%) | 0.09% +0.011 pp | 0.00% +0.000 pp | USD22.77 +70.8% | 4 qtrs — |
| 96 | PARALLEL ADVISORS, LLC | 14.0K -3.8K (-21.4%) | 544.1K +139.1K (+34.3%) | 0.06% -0.006 pp | 0.01% +0.003 pp | USD39.69 -2.0% | 23 qtrs — |
| 97 | OAK HARVEST INVESTMENT SERVICES | 13.5K -3.4K (-20.1%) | 524.6K +140.1K (+36.5%) | 0.05% -0.005 pp | 0.06% +0.012 pp | USD23.05 +68.8% | 5 qtrs — |
| 98 | HARBOR CAPITAL ADVISORS, INC. | 13.4K +261.0 (+2.0%) | 523.0K +223.0K (+74.3%) | 0.05% +0.008 pp | 0.04% +0.017 pp | USD21.75 +78.9% | 11 qtrs — |
| 99 | Y-INTERCEPT (HONG KONG) LTD | 13.2K +13.2K (+100.0%) | 515.3K +515.3K (+100.0%) | 0.05% +0.053 pp | 0.01% +0.012 pp | USD38.90 +0.0% | 9 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 113 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Health Care Services ETF XHS | 1.16% | 2.36M | 0.35% |
| 2 | Harbor Human Capital Factor US Small Cap ETF HAPS | 0.44% | 753.3K | 0.61% |
| 3 | iShares US Small Cap Value Factor ETF SVAL | 0.29% | 568.1K | 0.20% |
| 4 | Amplify Etho Climate Leadership U.S. ETF ETHO | 0.28% | 526.3K | 0.45% |
| 5 | Royce Quant Small-Cap Quality Value ETF SQLV | 0.21% | 60.0K | 0.60% |
| 6 | Inspire Small/Mid Cap ETF ISMD | 0.20% | 674.7K | 0.53% |
| 7 | Hartford Multifactor Small Cap ETF ROSC | 0.19% | 118.2K | 0.34% |
| 8 | iShares Micro-Cap ETF IWC | 0.16% | 2.37M | 0.60% |
| 9 | EA Bridgeway Omni Small-Cap Value ETF BSVO | 0.14% | 2.43M | 0.47% |
| 10 | iShares U.S. Healthcare Providers ETF IHF | 0.11% | 1.32M | 0.38% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.20
Bearish
Ratio by volume
0.35
Bearish
Buys
2
Sells
10
Shares acquired
6.8K
Shares disposed
19.1K
Cash buys
—
Cash sales
8.00
Net activity
-12,340
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,357 | 25.10 | 34.1K | 47,495 | I | ↗ |
| 2026-04-06 | MAETZOLD DEREK J | Director / Officer | M-Exempt | A | Common Stock | 6,214 | 2.39 | 14.9K | 27,693 | D | ↗ |
| 2026-03-26 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,357 | 25.55 | 34.7K | 50,209 | I | ↗ |
| 2026-03-26 | Cotton Rodney | Director | M-Exempt | A | Common Stock | 5,329 | 0.00 | — | 19,331 | D | ↗ |
| 2026-03-18 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 650 | 25.39 | 16.5K | 21,479 | D | ↗ |
| 2026-03-17 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 18,650 | 25.93 | 483.6K | 22,129 | D | ↗ |
| 2026-03-16 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 126 | 26.68 | 3.4K | 40,779 | D | ↗ |
| 2026-03-13 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 13,204 | 25.45 | 336.0K | 58,354 | D | ↗ |
| 2026-03-12 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 23,179 | 25.28 | 585.9K | 71,558 | D | ↗ |
| 2026-03-12 | Juvenal Tobin W | Officer | S-Sale | D | Common Stock | 20,863 | 25.24 | 526.6K | 86,825 | D | ↗ |
| 2026-03-11 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 279 | 26.11 | 7.3K | 3,336 | I | ↗ |
| 2026-03-05 | Stokes Frank | Officer | S-Sale | D | Common Stock | 6,001 | 27.98 | 167.9K | 60,085 | D | ↗ |
| 2026-03-05 | Cole G Bradley | Director | S-Sale | D | Common Stock | 2,655 | 28.51 | 75.7K | 19,309 | D | ↗ |
| 2026-03-04 | Stokes Frank | Officer | M-Exempt | A | Common Stock | 3,800 | 3.38 | 12.8K | 66,086 | D | ↗ |
| 2026-03-04 | Oelschlager Kristen M | Officer | M-Exempt | D | Restricted Stock Units | 13,811 | 0.00 | — | 27,621 | D | ↗ |
| 2026-03-04 | MAETZOLD DEREK J | Director / Officer | F-InKind | D | Common Stock | 17,931 | 28.17 | 505.1K | 105,821 | D | ↗ |
| 2026-03-04 | Juvenal Tobin W | Officer | M-Exempt | A | Common Stock | 25,771 | 0.00 | — | 118,087 | D | ↗ |
| 2026-03-03 | Stokes Frank | Officer | S-Sale | D | Common Stock | 1,700 | 27.81 | 47.3K | 52,483 | D | ↗ |
| 2026-03-03 | Oelschlager Kristen M | Officer | F-InKind | D | Common Stock | 2,427 | 27.57 | 66.9K | 20,068 | D | ↗ |
| 2026-03-03 | MAETZOLD DEREK J | Director / Officer | F-InKind | D | Common Stock | 19,043 | 27.57 | 525.0K | 64,655 | D | ↗ |
| 2026-03-03 | Juvenal Tobin W | Officer | F-InKind | D | Common Stock | 3,716 | 27.57 | 102.5K | 92,316 | D | ↗ |
| 2026-02-04 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 646 | 37.82 | 24.4K | 83,869 | D | ↗ |
| 2026-02-03 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 3,200 | 39.91 | 127.7K | 84,515 | D | ↗ |
| 2026-01-20 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 4,017 | 40.01 | 160.7K | 87,715 | D | ↗ |
| 2026-01-12 | Stokes Frank | Officer | A-Award | A | Common Stock | 8,124 | 0.00 | — | 58,450 | D | ↗ |
| 2026-01-12 | Oelschlager Kristen M | Officer | A-Award | A | Performance-Based Stock Unit | 9,207 | 0.00 | — | 9,207 | D | ↗ |
| 2026-01-12 | MAETZOLD DEREK J | Director / Officer | A-Award | A | Performance-Based Stock Unit | 62,219 | 0.00 | — | 62,219 | D | ↗ |
| 2026-01-12 | Juvenal Tobin W | Officer | A-Award | A | Common Stock | 9,207 | 0.00 | — | 96,032 | D | ↗ |
| 2026-01-06 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,339 | 40.10 | 53.7K | 29,513 | D | ↗ |
| 2026-01-05 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 2,678 | 38.09 | 102.0K | 30,852 | D | ↗ |
| 2025-12-22 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 830 | 40.35 | 33.5K | 33,530 | D | ↗ |
| 2025-12-17 | Oelschlager Kristen M | Officer | S-Sale | D | Common Stock | 14,888 | 39.31 | 585.3K | 12,323 | D | ↗ |
| 2025-12-17 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 509 | 40.04 | 20.4K | 34,360 | D | ↗ |
| 2025-12-16 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 12,821 | 38.55 | 494.3K | 34,869 | D | ↗ |
| 2025-12-15 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,012 | 39.30 | 39.8K | 47,690 | D | ↗ |
| 2025-12-11 | Stokes Frank | Officer | S-Sale | D | Common Stock | 4,496 | 37.45 | 168.4K | 50,326 | D | ↗ |
| 2025-12-11 | Juvenal Tobin W | Officer | S-Sale | D | Common Stock | 13,200 | 37.48 | 494.7K | 86,825 | D | ↗ |
| 2025-12-10 | Stokes Frank | Officer | M-Exempt | D | Restricted Stock Units | 6,170 | 0.00 | — | 0 | D | ↗ |
| 2025-12-10 | Oelschlager Kristen M | Officer | M-Exempt | D | Restricted Stock Units | 6,170 | 0.00 | — | 0 | D | ↗ |
| 2025-12-10 | MAETZOLD DEREK J | Director / Officer | M-Exempt | A | Common Stock | 15,424 | 0.00 | — | 73,285 | D | ↗ |
| 2025-12-10 | Juvenal Tobin W | Officer | M-Exempt | D | Restricted Stock Units | 6,170 | 0.00 | — | 0 | D | ↗ |
| 2025-12-09 | Stokes Frank | Officer | M-Exempt | D | Restricted Stock Units | 14,616 | 0.00 | — | 14,617 | D | ↗ |
| 2025-12-09 | Oelschlager Kristen M | Officer | M-Exempt | A | Common Stock | 15,961 | 0.00 | — | 28,284 | D | ↗ |
| 2025-12-09 | MAETZOLD DEREK J | Director / Officer | F-InKind | D | Common Stock | 13,181 | 38.25 | 504.2K | 57,861 | D | ↗ |
| 2025-12-09 | Juvenal Tobin W | Officer | M-Exempt | D | Restricted Stock Units | 15,961 | 0.00 | — | 15,961 | D | ↗ |
| 2025-12-04 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,339 | 40.03 | 53.6K | 37,547 | D | ↗ |
| 2025-12-02 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 2,678 | 39.23 | 105.1K | 38,886 | D | ↗ |
| 2025-11-26 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 4,258 | 40.09 | 170.7K | 41,564 | D | ↗ |
| 2025-11-25 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 5,115 | 40.05 | 204.9K | 45,822 | D | ↗ |
| 2025-11-20 | Juvenal Tobin W | Officer | M-Exempt | A | Common Stock | 4,693 | 3.38 | 15.9K | 89,288 | D | ↗ |
| 2025-11-18 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 2,678 | 34.02 | 91.1K | 50,937 | D | ↗ |
| 2025-11-12 | Juvenal Tobin W | Officer | S-Sale | D | Common Stock | 200 | 35.40 | 7.1K | 84,527 | D | ↗ |
| 2025-11-11 | Stokes Frank | Officer | S-Sale | D | Common Stock | 5,388 | 35.08 | 189.0K | 43,328 | D | ↗ |
| 2025-11-11 | Oelschlager Kristen M | Officer | S-Sale | D | Common Stock | 18,932 | 35.10 | 664.5K | 12,323 | D | ↗ |
| 2025-11-11 | Juvenal Tobin W | Officer | S-Sale | D | Common Stock | 500 | 35.39 | 17.7K | 84,527 | D | ↗ |
| 2025-11-05 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 2,678 | 31.85 | 85.3K | 53,615 | D | ↗ |
| 2025-11-04 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 6,458 | 30.41 | 196.4K | 56,530 | D | ↗ |
| 2025-10-31 | Oelschlager Kristen M | Officer | S-Sale | D | Common Stock | 12,678 | 25.04 | 317.5K | 27,569 | D | ↗ |
| 2025-10-20 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,339 | 22.44 | 30.0K | 62,988 | D | ↗ |
| 2025-10-02 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,339 | 22.58 | 30.2K | 64,327 | D | ↗ |
| 2025-09-17 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,339 | 21.97 | 29.4K | 65,666 | D | ↗ |
| 2025-09-02 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,339 | 23.93 | 32.0K | 67,005 | D | ↗ |
| 2025-08-27 | Oelschlager Kristen M | Officer | S-Sale | D | Common Stock | 18,007 | 21.69 | 390.6K | 100,937 | I | ↗ |
| 2025-08-15 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,339 | 20.04 | 26.8K | 68,344 | D | ↗ |
| 2025-08-13 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 43,019 | 19.50 | 839.0K | 69,683 | D | ↗ |
| 2025-08-08 | Stokes Frank | Officer | M-Exempt | D | Performance-Based Stock Unit | 9,744 | 0.00 | — | 0 | D | ↗ |
| 2025-08-08 | Oelschlager Kristen M | Officer | M-Exempt | A | Common Stock | 10,640 | 0.00 | — | 174,604 | D | ↗ |
| 2025-08-08 | MAETZOLD DEREK J | Director / Officer | F-InKind | D | Common Stock | 23,972 | 19.36 | 464.1K | 112,702 | D | ↗ |
| 2025-08-08 | Juvenal Tobin W | Officer | M-Exempt | D | Performance-Based Stock Unit | 10,640 | 0.00 | — | 0 | D | ↗ |
| 2025-06-27 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 4,944 | 20.30 | 100.4K | 69,683 | D | ↗ |
| 2025-05-22 | Olson Tiffany | Director | A-Award | A | Restricted Stock Units | 13,667 | 0.00 | — | 13,667 | D | ↗ |
| 2025-05-22 | Harrison Miles | Director | A-Award | A | Restricted Stock Units | 13,667 | 0.00 | — | 13,667 | D | ↗ |
| 2025-05-22 | Goldberg Ellen | Director | A-Award | A | Restricted Stock Units | 13,667 | 0.00 | — | 13,667 | D | ↗ |
| 2025-05-22 | Cotton Rodney | Director | A-Award | A | Restricted Stock Units | 13,667 | 0.00 | — | 13,667 | D | ↗ |
| 2025-05-22 | Cole G Bradley | Director | A-Award | A | Restricted Stock Units | 13,667 | 0.00 | — | 13,667 | D | ↗ |
| 2025-05-22 | Caple Kim | Director | A-Award | A | Restricted Stock Units | 13,667 | 0.00 | — | 13,667 | D | ↗ |
| 2025-05-22 | BRADBURY DANIEL | Director | A-Award | A | Restricted Stock Units | 13,667 | 0.00 | — | 13,667 | D | ↗ |
| 2025-05-21 | Olson Tiffany | Director | M-Exempt | A | Common Stock | 8,673 | 0.00 | — | 25,906 | D | ↗ |
| 2025-05-21 | Harrison Miles | Director | M-Exempt | D | Restricted Stock Units | 8,673 | 0.00 | — | 0 | D | ↗ |
| 2025-05-21 | Goldberg Ellen | Director | M-Exempt | D | Restricted Stock Units | 8,673 | 0.00 | — | 0 | D | ↗ |
| 2025-05-21 | Cotton Rodney | Director | M-Exempt | A | Common Stock | 8,673 | 0.00 | — | 14,002 | D | ↗ |
| 2025-05-21 | Cole G Bradley | Director | M-Exempt | D | Restricted Stock Units | 8,673 | 0.00 | — | 0 | D | ↗ |
| 2025-05-21 | Caple Kim | Director | M-Exempt | D | Restricted Stock Units | 8,673 | 0.00 | — | 0 | D | ↗ |
| 2025-05-21 | BRADBURY DANIEL | Director | M-Exempt | D | Restricted Stock Units | 8,673 | 0.00 | — | 0 | D | ↗ |
| 2025-05-08 | Cotton Rodney | Director | A-Award | A | Restricted Stock Units | 1,952 | 0.00 | — | 1,952 | D | ↗ |
| 2025-04-21 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,731 | 21.52 | 37.2K | 51,910 | I | ↗ |
| 2025-04-09 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 137 | 20.22 | 2.8K | 4,440 | I | ↗ |
| 2025-04-08 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 30 | 20.03 | 600.90 | 4,578 | I | ↗ |
| 2025-03-26 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,236 | 20.30 | 25.1K | 77,099 | D | ↗ |
| 2025-03-26 | Cotton Rodney | Director | M-Exempt | D | Restricted Stock Units | 5,329 | 0.00 | — | 10,659 | D | ↗ |
| 2025-03-10 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 2,130 | 19.52 | 41.6K | 78,335 | D | ↗ |
| 2025-03-07 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 189 | 20.74 | 3.9K | 67,042 | I | ↗ |
| 2025-03-04 | Stokes Frank | Officer | A-Award | A | Restricted Stock Units | 47,838 | 0.00 | — | 47,838 | D | ↗ |
| 2025-02-20 | Stokes Frank | Officer | S-Sale | D | Common Stock | 8,046 | 26.70 | 214.8K | 35,319 | D | ↗ |
| 2025-02-05 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 1,425 | 28.17 | 40.1K | 0 | I | ↗ |
| 2025-01-13 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 267 | 27.51 | 7.3K | 60,780 | I | ↗ |
| 2025-01-07 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 124 | 30.14 | 3.7K | 71,586 | I | ↗ |
| 2025-01-06 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 325 | 28.42 | 9.2K | 62,144 | I | ↗ |
| 2025-01-06 | Juvenal Tobin W | Officer | S-Sale | D | Common Stock | 2,230 | 30.00 | 66.9K | 69,943 | D | ↗ |
| 2025-01-06 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 472 | 29.82 | 14.1K | 5,017 | I | ↗ |
| 2024-12-17 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 9,252 | 28.33 | 262.1K | 84,874 | D | ↗ |
| 2024-12-16 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 11,059 | 28.83 | 318.9K | 94,126 | D | ↗ |
| 2024-12-13 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 113 | 28.47 | 3.2K | 5,747 | I | ↗ |
| 2024-12-10 | Stokes Frank | Officer | F-InKind | D | Common Stock | 900 | 29.63 | 26.7K | 39,969 | D | ↗ |
| 2024-12-10 | Oelschlager Kristen M | Officer | M-Exempt | A | Common Stock | 6,169 | 0.00 | — | 154,148 | D | ↗ |
| 2024-12-10 | MAETZOLD DEREK J | Director / Officer | M-Exempt | D | Restricted Stock Units | 5,362 | 0.00 | — | 0 | D | ↗ |
| 2024-12-10 | Juvenal Tobin W | Officer | M-Exempt | D | Restricted Stock Units | 1,750 | 0.00 | — | 0 | D | ↗ |
| 2024-12-09 | Stokes Frank | Officer | M-Exempt | D | Restricted Stock Units | 14,617 | 0.00 | — | 29,233 | D | ↗ |
| 2024-12-09 | Oelschlager Kristen M | Officer | M-Exempt | A | Common Stock | 15,961 | 0.00 | — | 150,965 | D | ↗ |
| 2024-12-09 | MAETZOLD DEREK J | Director / Officer | M-Exempt | D | Restricted Stock Units | 33,496 | 0.00 | — | 66,991 | D | ↗ |
| 2024-12-09 | Juvenal Tobin W | Officer | F-InKind | D | Common Stock | 3,887 | 30.91 | 120.1K | 66,252 | D | ↗ |
| 2024-12-05 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,972 | 31.35 | 61.8K | 85,748 | D | ↗ |
| 2024-12-03 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 348 | 31.32 | 10.9K | 10,034 | I | ↗ |
| 2024-11-15 | Stokes Frank | Officer | S-Sale | D | Common Stock | 6,123 | 29.87 | 182.9K | 31,623 | D | ↗ |
| 2024-11-12 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,972 | 34.15 | 67.3K | 87,720 | D | ↗ |
| 2024-11-05 | Juvenal Tobin W | Officer | M-Exempt | A | Common Stock | 3,507 | 3.38 | 11.9K | 57,685 | D | ↗ |
| 2024-11-04 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 15 | 33.16 | 497.33 | 75,626 | I | ↗ |
| 2024-11-01 | Juvenal Tobin W | Officer | M-Exempt | A | Common Stock | 1,100 | 3.38 | 3.7K | 57,278 | D | ↗ |
| 2024-11-01 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 1,322 | 33.90 | 44.8K | 18,746 | I | ↗ |
| 2024-10-14 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,010 | 32.27 | 32.6K | 76,636 | I | ↗ |
| 2024-10-08 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 150 | 30.27 | 4.5K | 7,060 | I | ↗ |
| 2024-10-07 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 5,017 | 29.44 | 147.7K | 20,068 | I | ↗ |
| 2024-10-04 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 986 | 28.73 | 28.3K | 94,622 | D | ↗ |
| 2024-09-16 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,972 | 30.97 | 61.1K | 95,608 | — | ↗ |
| 2024-09-11 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 512 | 30.32 | 15.5K | 79,666 | — | ↗ |
| 2024-09-09 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 996 | 29.46 | 29.3K | 98,576 | — | ↗ |
| 2024-09-05 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 5,017 | 29.02 | 145.6K | 25,085 | — | ↗ |
| 2024-09-04 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 298 | 30.02 | 8.9K | 99,572 | — | ↗ |
| 2024-09-03 | Oelschlager Kristen M | Officer | S-Sale | D | Common Stock | 4,582 | 29.00 | 132.9K | 136,091 | — | ↗ |
| 2024-09-03 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 213 | 30.05 | 6.4K | 80,843 | — | ↗ |
| 2024-08-30 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 322 | 30.10 | 9.7K | 100,287 | — | ↗ |
| 2024-08-29 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 688 | 30.08 | 20.7K | 81,221 | — | ↗ |
| 2024-08-26 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 12 | 30.05 | 360.59 | 8,344 | — | ↗ |
| 2024-08-23 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,037 | 30.09 | 31.2K | 102,019 | — | ↗ |
| 2024-08-12 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 5,021 | 26.65 | 133.8K | 30,102 | — | ↗ |
| 2024-08-09 | Stokes Frank | Officer | A-Award | A | Common Stock | 9,745 | 0.00 | — | 40,568 | — | ↗ |
| 2024-08-09 | Oelschlager Kristen M | Officer | F-InKind | D | Common Stock | 2,804 | 26.83 | 75.2K | 140,673 | — | ↗ |
| 2024-08-09 | MAETZOLD DEREK J | Director / Officer | A-Award | A | Common Stock | 66,991 | 0.00 | — | 124,884 | — | ↗ |
| 2024-08-09 | Juvenal Tobin W | Officer | A-Award | A | Common Stock | 10,641 | 0.00 | — | 58,770 | — | ↗ |
| 2024-08-07 | Stokes Frank | Officer | S-Sale | D | Common Stock | 5,400 | 26.13 | 141.1K | 30,823 | — | ↗ |
| 2024-08-01 | Oelschlager Kristen M | Officer | S-Sale | D | Common Stock | 4,225 | 23.77 | 100.4K | 132,836 | — | ↗ |
| 2024-07-29 | Oelschlager Kristen M | Officer | S-Sale | D | Common Stock | 2,793 | 22.06 | 61.6K | 145,825 | — | ↗ |
| 2024-07-14 | Goldberg Ellen | Director | M-Exempt | D | Restricted Stock Units | 440 | 0.00 | — | 0 | — | ↗ |
| 2024-07-14 | Caple Kim | Director | M-Exempt | A | Common Stock | 440 | 0.00 | — | 13,781 | — | ↗ |
| 2024-07-01 | Olson Tiffany | Director | M-Exempt | A | Common Stock | 830 | 0.00 | — | 17,233 | — | ↗ |
| 2024-07-01 | Oelschlager Kristen M | Officer | S-Sale | D | Common Stock | 2,793 | 21.22 | 59.3K | 148,618 | — | ↗ |
| 2024-06-03 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,192 | 23.39 | 27.9K | 82,502 | — | ↗ |
| 2024-05-25 | Olson Tiffany | Director | M-Exempt | A | Common Stock | 8,636 | 0.00 | — | 16,403 | — | ↗ |
| 2024-05-25 | Harrison Miles | Director | M-Exempt | D | Restricted Stock Units | 8,636 | 0.00 | — | 0 | — | ↗ |
| 2024-05-25 | Goldberg Ellen | Director | M-Exempt | D | Restricted Stock Units | 8,636 | 0.00 | — | 0 | — | ↗ |
| 2024-05-25 | Cole G Bradley | Director | M-Exempt | D | Restricted Stock Units | 8,636 | 0.00 | — | 0 | — | ↗ |
| 2024-05-25 | Caple Kim | Director | M-Exempt | D | Restricted Stock Units | 8,636 | 0.00 | — | 0 | — | ↗ |
| 2024-05-25 | BRADBURY DANIEL | Director | M-Exempt | A | Common Stock | 8,636 | 0.00 | — | 13,291 | — | ↗ |
| 2024-05-23 | Olson Tiffany | Director | A-Award | A | Restricted Stock Units | 8,673 | 0.00 | — | 8,673 | — | ↗ |
| 2024-05-23 | Harrison Miles | Director | A-Award | A | Restricted Stock Units | 8,673 | 0.00 | — | 8,673 | — | ↗ |
| 2024-05-23 | Goldberg Ellen | Director | A-Award | A | Restricted Stock Units | 8,673 | 0.00 | — | 8,673 | — | ↗ |
| 2024-05-23 | Cotton Rodney | Director | A-Award | A | Restricted Stock Units | 6,777 | 0.00 | — | 6,777 | D | ↗ |
| 2024-05-23 | Cole G Bradley | Director | A-Award | A | Restricted Stock Units | 8,673 | 0.00 | — | 8,673 | — | ↗ |
| 2024-05-23 | Caple Kim | Director | A-Award | A | Restricted Stock Units | 8,673 | 0.00 | — | 8,673 | — | ↗ |
| 2024-05-23 | BRADBURY DANIEL | Director | A-Award | A | Restricted Stock Units | 8,673 | 0.00 | — | 8,673 | — | ↗ |
| 2024-05-23 | Aspinall Mara G. | Director | M-Exempt | A | Common Stock | 8,636 | 0.00 | — | 44,139 | — | ↗ |
| 2024-05-14 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,067 | 24.17 | 25.8K | 83,839 | — | ↗ |
| 2024-05-10 | Olson Tiffany | Director | M-Exempt | A | Common Stock | 487 | 0.00 | — | 7,767 | — | ↗ |
| 2024-05-06 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 386 | 24.72 | 9.5K | 9,297 | — | ↗ |
| 2024-05-06 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 7,967 | 24.64 | 196.3K | 9,981 | — | ↗ |
| 2024-04-23 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 215 | 20.11 | 4.3K | 86,118 | — | ↗ |
| 2024-04-12 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,947 | 20.35 | 39.6K | 65,418 | — | ↗ |
| 2024-04-08 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 761 | 20.45 | 15.6K | 42,516 | — | ↗ |
| 2024-04-05 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 4,019 | 20.86 | 83.8K | 18,763 | — | ↗ |
| 2024-04-04 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 3,125 | 21.45 | 67.0K | 22,782 | — | ↗ |
| 2024-04-03 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 386 | 21.70 | 8.4K | 10,071 | — | ↗ |
| 2024-03-26 | Cotton Rodney | Director | A-Award | A | Restricted Stock Units | 15,988 | 0.00 | — | 15,988 | — | ↗ |
| 2024-03-21 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 12 | 20.70 | 248.40 | 10,455 | — | ↗ |
| 2024-03-20 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 374 | 20.27 | 7.6K | 10,467 | — | ↗ |
| 2024-03-07 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,222 | 20.77 | 25.4K | 89,754 | — | ↗ |
| 2024-03-05 | MAETZOLD DEREK J | Director / Officer | M-Exempt | D | Stock option (right to buy) | 10,686 | 3.72 | 39.8K | 0 | — | ↗ |
| 2024-03-04 | Stokes Frank | Officer | A-Award | A | Restricted Stock Units | 48,744 | 0.00 | — | 48,744 | — | ↗ |
| 2024-03-04 | Oelschlager Kristen M | Officer | A-Award | A | Restricted Stock Units | 55,243 | 0.00 | — | 55,243 | — | ↗ |
| 2024-03-04 | MAETZOLD DEREK J | Director / Officer | A-Award | A | Restricted Stock Units | 124,437 | 0.00 | — | 124,437 | — | ↗ |
| 2024-03-04 | Juvenal Tobin W | Officer | A-Award | A | Restricted Stock Units | 55,243 | 0.00 | — | 55,243 | — | ↗ |
| 2024-03-04 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 5,701 | 20.44 | 116.5K | 28,169 | — | ↗ |
| 2024-02-07 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 658 | 23.20 | 15.3K | 57,302 | — | ↗ |
| 2024-02-06 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 3,362 | 23.63 | 79.4K | 34,578 | — | ↗ |
| 2024-02-05 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 931 | 23.42 | 21.8K | 37,954 | — | ↗ |
| 2024-01-05 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 1,741 | 20.36 | 35.4K | 41,833 | — | ↗ |
| 2024-01-04 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 6,225 | 20.40 | 127.0K | 43,591 | — | ↗ |
| 2024-01-02 | Juvenal Tobin W | Officer | M-Exempt | A | Common Stock | 3,400 | 3.38 | 11.5K | 46,857 | — | ↗ |
| 2023-12-29 | Oelschlager Kristen M | Officer | M-Exempt | A | Common Stock | 1,197 | 2.36 | 2.8K | 138,884 | — | ↗ |
| 2023-12-28 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 59 | 22.17 | 1.3K | 11,629 | — | ↗ |
| 2023-12-27 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 119 | 21.90 | 2.6K | 11,693 | — | ↗ |
| 2023-12-26 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 77 | 21.93 | 1.7K | 11,807 | — | ↗ |
| 2023-12-22 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 78 | 21.96 | 1.7K | 11,889 | — | ↗ |
| 2023-12-21 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 448 | 21.40 | 9.6K | 81,894 | — | ↗ |
| 2023-12-20 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 212 | 21.05 | 4.5K | 82,342 | — | ↗ |
| 2023-12-19 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 350 | 20.84 | 7.3K | 12,202 | — | ↗ |
| 2023-12-18 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 158 | 20.27 | 3.2K | 12,558 | — | ↗ |
| 2023-12-15 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 118 | 20.21 | 2.4K | 12,716 | — | ↗ |
| 2023-12-14 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 1,019 | 20.86 | 21.3K | 12,866 | — | ↗ |
| 2023-12-13 | MAETZOLD DEREK J | Director / Officer | S-Sale | D | Common Stock | 419 | 20.21 | 8.5K | 13,879 | — | ↗ |
| 2023-12-13 | BRADBURY DANIEL | Director | S-Sale | D | Common Stock | 399 | 20.04 | 8.0K | 49,796 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-37.5K
Shares Outstanding
30.30M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Derek J. Maetzold President and CEO | 751.4K | — | 4.98M | — | 1.04M | 21.4K | 6.79M | 73.34% | ↗ |
| 2 | 2025 | Frank Stokes Chief Financial Officer | 522.5K | 14.4K | 1.42M | — | 374.8K | 90.2K | 2.42M | 58.60% | ↗ |
| 3 | 2025 | Tobin W. Juvenal Chief Commercial Officer | 529.2K | 14.6K | 1.42M | — | 379.5K | 21.4K | 2.36M | 60.02% | ↗ |
| 4 | 2025 | Kristen M. Oelschlager Chief Operating Officer | 529.2K | 14.6K | 1.42M | — | 379.5K | 21.4K | 2.36M | 60.02% | ↗ |
| 5 | 2024 | Derek J. Maetzold President and CEO | 715.6K | — | 5.28M | — | 921.7K | 20.3K | 6.94M | 76.12% | ↗ |
| 6 | 2024 | Kristen M. Oelschlager Chief Operating Officer | 506.4K | 13.9K | 1.56M | — | 342.7K | 20.2K | 2.45M | 63.91% | ↗ |
| 7 | 2024 | Tobin W. Juvenal Chief Commercial Officer | 506.4K | 13.9K | 1.56M | — | 342.7K | 20.2K | 2.45M | 63.91% | ↗ |
| 8 | 2024 | Frank Stokes Chief Financial Officer | 500.0K | 13.8K | 1.38M | — | 338.4K | 74.6K | 2.31M | 59.82% | ↗ |
| 9 | 2023 | Derek J. Maetzold President and CEO | 686.4K | — | — | — | 893.4K | 26.2K | 1.61M | 0.00% | ↗ |
| 10 | 2023 | Frank Stokes Chief Financial Officer | 488.8K | 4.9K | — | — | 316.7K | 69.8K | 880.3K | 0.00% | ↗ |
| 11 | 2023 | Tobin W. Juvenal Chief Commercial Officer | 482.3K | 14.5K | — | — | 312.5K | 19.8K | 829.1K | 0.00% | ↗ |
| 12 | 2023 | Kristen M. Oelschlager Chief Operating Officer | 482.3K | 9.6K | — | — | 312.5K | 24.0K | 828.5K | 0.00% | ↗ |
| 13 | 2022 | Derek J. Maetzold President and CEO | 660.0K | — | 6.10M | — | 771.4K | 18.3K | 7.55M | 80.81% | ↗ |
| 14 | 2022 | Tobin W. Juvenal Chief Commercial Officer | 455.0K | 13.7K | 1.92M | — | 295.8K | 18.3K | 2.70M | 71.03% | ↗ |
| 15 | 2022 | Kristen M. Oelschlager Chief Operating Officer | 455.0K | 13.7K | 1.92M | — | 295.8K | 18.3K | 2.70M | 71.03% | ↗ |
| 16 | 2022 | Frank Stokes Chief Financial Officer | 470.0K | 4.7K | 1.76M | — | 305.5K | 69.2K | 2.61M | 67.42% | ↗ |
| 17 | 2021 | Derek J. Maetzold President and Chief Executive Officer | 625.0K | — | 2.50M | 2.66M | 722.5K | 17.4K | 6.52M | 79.07% | ↗ |
| 18 | 2021 | Derek J. Maetzold President and CEO | 625.0K | — | 2.50M | 2.66M | 722.5K | 17.4K | 6.52M | 79.07% | ↗ |
| 19 | 2021 | Frank Stokes Chief Financial Officer | 450.0K | 4.5K | 1,000.0K | 1.06M | 289.8K | 58.7K | 2.87M | 71.98% | ↗ |
| 20 | 2021 | Kristen M. Oelschlager Chief Operating Officer | 425.0K | 8.5K | 1,000.0K | 1.06M | 273.7K | 17.4K | 2.79M | 74.00% | ↗ |
| 21 | 2021 | Kristen Oelschlager, R.N. Chief Operating Officer | 425.0K | 8.5K | 1,000.0K | 1.06M | 273.7K | 17.4K | 2.79M | 74.00% | ↗ |
| 22 | 2021 | Tobin W. Juvenal Chief Commercial Officer | 425.0K | 8.5K | 1,000.0K | 1.06M | 273.7K | 17.4K | 2.79M | 74.00% | ↗ |
| 23 | 2020 | Derek J. Maetzold President and Chief Executive Officer | 550.0K | — | 1.27M | 3.06M | 457.6K | 11.4K | 5.34M | 80.93% | ↗ |
| 24 | 2020 | Derek J. Maetzold President and CEO | 550.0K | — | 1.27M | 3.06M | 457.6K | 11.4K | 5.34M | 80.93% | ↗ |
| 25 | 2020 | Frank Stokes Chief Financial Officer | 400.0K | 4.0K | 473.3K | 1.09M | 208.0K | 44.3K | 2.22M | 70.40% | ↗ |
| 26 | 2020 | Bernhard E. Spiess Chief Business Officer | 350.0K | 3.2K | 355.0K | 806.9K | 163.8K | 11.4K | 1.34M | 87.01% | ↗ |
| 27 | 2019 | Derek J. Maetzold President and Chief Executive Officer | 769.6K | 18.7K | — | 2.99M | 341.8K | 11.2K | 4.13M | 72.38% | ↗ |
| 28 | 2019 | Frank Stokes Chief Financial Officer | 327.1K | 7.7K | — | 968.9K | 141.7K | 52.8K | 1.50M | 64.67% | ↗ |
| 29 | 2019 | Federico A. Monzon, M.D. Chief Medical Officer | 326.8K | 8.1K | — | 644.4K | 148.1K | 11.2K | 1.14M | 56.59% | ↗ |
| 30 | 2018 | Derek J. Maetzold President and Chief Executive Officer | 409.5K | — | — | 161.0K | 206.0K | 14.2K | 790.8K | 20.37% | ↗ |
| 31 | 2018 | Frank Stokes Chief Financial Officer | 275.0K | — | — | 177.3K | 96.3K | 44.7K | 593.3K | 29.89% | ↗ |
| 32 | 2018 | Federico A. Monzon, M.D. Chief Medical Officer | 317.1K | — | — | 33.4K | 112.4K | 11.0K | 473.9K | 7.05% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Derek J. Maetzold | Founder, Chief Executive Officer, President & Director | 2M | male |
| Frank Stokes | Chief Financial Officer & Treasurer | 1M | male |
| Kristen Oelschlager | Chief Operating Officer | 944.7K | female |
| Tobin W. Juvenal | Chief Commercial Officer | 944.7K | male |
| Kevin Doman | Vice President of Sales | — | male |
| Matthew Goldberg | Senior Vice President of Medical | — | — |
| Camilla Zuckero | Vice President of Investor Relations & Corporate Affairs | — | female |
| Trisha Poteet | Senior VP of Clinical Services & Manufacturing Operations | — | female |
| Hillary Caruso | Chief of Staff | — | — |
| Jay Braxton | Vice President of Marketing & Brand Manager of Uveal Melanoma (UM) | — | — |
| Keli Greenberg | Vice President of Human Resources | — | female |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2022-03-15 | 2022-04-17 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-12-23 | 2021-01-11 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-12-21 | 2021-01-07 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CSTL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
